March 17, 2025 · Form 4 insider transaction
Dickinson Andrew D sold 2,500 shares of Gilead Sciences, Inc. at $110.53 per share, a transaction worth $276.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024.